KR
Krishnam Raju Vegesna
About Krishnam Raju Vegesna
Data last updated:
Krishnam Raju Vegesna has 22 years in corporate governance. Holds Director role. Currently with 1 company, including Rovertis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rovertis Pharmaceuticals Private Limited at ₹63.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rovertis Pharmaceuticals Private Limited U24239TG2004PTC044325 | Director | 04 Oct 2004 | 2004 | ₹63.3 Lakh (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishnam Raju Vegesna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishnam Raju Vegesna
Krishnam Raju Vegesna has 22 years in corporate governance. Holds Director role. Currently with 1 company, including Rovertis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rovertis Pharmaceuticals Private Limited at ₹63.3 Lakh (FY 2023).
Krishnam Raju Vegesna is associated with 1 company as Director, including Rovertis Pharmaceuticals Private Limited (₹63.3 Lakh).
Krishnam Raju Vegesna has expertise in General Business.
Krishnam Raju Vegesna has 22 years in corporate governance.
By reported revenue, the largest current company of Krishnam Raju Vegesna is Rovertis Pharmaceuticals Private Limited, with revenue of ₹63.3 Lakh (FY 2023).
Krishnam Raju Vegesna currently holds positions at 1 company: Rovertis Pharmaceuticals Private Limited (₹63.3 Lakh).